# Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

> **NCT00167219** · PHASE1,PHASE2 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 15 (actual)

## Conditions studied

- Juvenile Myelomonocytic Leukemia

## Interventions

- **BIOLOGICAL:** Stem Cell Transplant
- **DRUG:** Preparative Regimen

## Key facts

- **NCT ID:** NCT00167219
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11-18
- **Primary completion:** 2022-07-12
- **Final completion:** 2023-08-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167219, "Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00167219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*